Protagonist Therapeutics Stock Story
| PTGX Stock | USD 26.85 0.24 0.90% |
Slightly above 60% of all Protagonist Therapeutics' investors are looking to take a long position. The analysis of the overall investor sentiment regarding Protagonist Therapeutics suggests that some traders are interested. Protagonist Therapeutics' investor sentiment overview provides quick insight into current market opportunities from investing in Protagonist Therapeutics. The current market sentiment, together with Protagonist Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Protagonist Therapeutics stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Protagonist Therapeutics stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Protagonist daily returns and investor perception about the current price of Protagonist Therapeutics as well as its diversification or hedging effects on your existing portfolios.
Protagonist |
Requested story not found. it has been either deleted or moved. View all stories for Protagonist Therapeutics.
Protagonist Therapeutics Latest Timeline
Protagonist Therapeutics is listed for 26.85. About 98.0% of the company shares are owned by institutional investors. The book value of Protagonist Therapeutics was at this time reported as 5.83. The company recorded a loss per share of 1.39. Protagonist Therapeutics had not issued any dividends in recent years.Check out Protagonist Therapeutics Hype Analysis, Protagonist Therapeutics Correlation and Protagonist Therapeutics Performance. For more information on how to buy Protagonist Stock please use our How to Invest in Protagonist Therapeutics guide.Note that the Protagonist Therapeutics information on this page should be used as a complementary analysis to other Protagonist Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Complementary Tools for Protagonist Stock analysis
When running Protagonist Therapeutics' price analysis, check to measure Protagonist Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagonist Therapeutics is operating at the current time. Most of Protagonist Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagonist Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagonist Therapeutics' price. Additionally, you may evaluate how the addition of Protagonist Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |
Is Protagonist Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Protagonist Therapeutics. If investors know Protagonist will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Protagonist Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.39) | Revenue Per Share 1.057 | Quarterly Revenue Growth (1.00) | Return On Assets (0.19) | Return On Equity (0.29) |
The market value of Protagonist Therapeutics is measured differently than its book value, which is the value of Protagonist that is recorded on the company's balance sheet. Investors also form their own opinion of Protagonist Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Protagonist Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Protagonist Therapeutics' market value can be influenced by many factors that don't directly affect Protagonist Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Protagonist Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Protagonist Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Protagonist Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.